Passage BIO, Inc. - 8-K Filing
Passage Bio receives Nasdaq deficiency notice for failing to meet $2.5 million minimum stockholders' equity requirement. (Items: 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing)
Tickers: $PASG
Read the full article at SEC EDGAR
Part of the story TNL Mediagene Regains Nasdaq Compliance Following Sale of Japanese Subsidiary (3 articles)